Melanoma-derived EVs also play a key role in developing an immune-tolerant microenvironment (Suman and Markovic, 2023) as it increases the expression of programmed cell death ligand 1 (PD-L1) on immature myeloid cells, which suppress T-cell activation (Fleming et al., 2019). The gene discussed is CD274; the disease is melanoma.